A careful family history assessment by your physician is appropriate
Medical Disclaimer This article is for educational purposes only and should not replace individualized medical advice, diagnosis, or treatment
In this regard, it is noteworthy that a selective glucagon receptor antagonist increased hepatic fat in patients with T2D 23
Belle Health marketing claims ongoing provider support and check-ins, which should include side effect management
May 13th, 2025: Emerging Health Concerns Linked to Ozempic and Related GLP-1 Medications As the use of GLP-1 drugs like Ozempic, Wegovy, and Zepbound continues to rise, doctors are reporting a concerning side effect: Ozempic feet. This term describes the discomfort and pain some users experience as a result of rapid weight loss, which reduces the natural fat padding on the soles of the feet